相关实验视频

Updated: Jul 13, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

减少长期使用二二烯受体激活剂:与初级保健利益相关者进行深入访谈研究

Kristien Coteur¹, Sanne Peters², Pieter Jansen¹

¹Department of Public Health and Primary Care, Academic Center for General Practice, KU Leuven, Leuven, Belgium.

Health expectations : an international journal of public participation in health care and health policy

|October 18, 2023

概括

长期使用二氨酸受体激活剂 (BZRA) 治疗失眠是复杂的. 社会信仰,协作护理和以患者为中心的目标是减少对这些药物的依赖的关键.

科学领域:

药理学药理学是指药理学的学科.
公共卫生公共卫生
主要护理医学医疗保健

背景情况:

长期使用二二胺受体激动剂 (BZRA) 治疗失眠是一个重大的公共卫生挑战.
目前的初级保健方法不足以解决这个问题的多方面的性质.

研究的目的:

从患者,全科医生 (GP) 和药剂师的角度探索影响BZRA长期用于失眠的因素.
确定减少BZRA对初级保健的依赖的障碍和促进因素.

主要方法:

采用基于理论的方法进行定性研究.
在比利时的初级保健中,与24名参与者 (9名患者,6名全科医生,9名药剂师) 进行了深入的半结构面试.
使用框架方法进行主题分析,在理论领域框架内进行解释.

主要成果:

社会观点,医疗保健实践和患者对催眠使用的行为之间存在反射关系.
行为变化受到环境和社会支持的影响,突出了所有利益相关者之间需要建立合作关系的需要.
确定了六个关键因素:社会信仰,非药物治疗机会,协作初级保健,以患者为中心的目标,知情同意和自我管理.

结论:

长期使用BZRA治疗失眠是一种复杂的公共卫生问题,在初级保健中存在严重的中止障碍.
组织和个人障碍阻碍了减少BZRA使用的努力.
非医疗化的患者-GP关系对于降低处方率和授权利益相关者减少长期BZRA使用至关重要.

关键词:

这种类型的 benzodiazepines.抑郁症的描述抑郁症的描述一般的医生一般的医生建立在基础上的理论理论.药物治疗管理药物治疗管理药剂师是药剂师,药剂师是药剂师.初级医疗保健是一项主要的医疗保健服务.

更多相关视频

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

相关概念视频

CNS Depressants: Barbiturates and Benzodiazepines

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

Anxiolytic Drugs: Benzodiazepines and Buspirone

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

Sedatives and Hypnotics Drugs: Benzodiazepines

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

Sedatives and Hypnotics: Overview

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...